{"title":"辛伐他汀/非诺贝特联合治疗血脂异常:现有证据","authors":"José G. Jiménez-Montero, G. Haft","doi":"10.2147/RRED.S50952","DOIUrl":null,"url":null,"abstract":"(unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Research and Reports in Endocrine Disorders 2015:5 1–13 Research and Reports in Endocrine Disorders Dovepress","PeriodicalId":90317,"journal":{"name":"Research and reports in endocrine disorders","volume":"5 1","pages":"1-13"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRED.S50952","citationCount":"0","resultStr":"{\"title\":\"Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence\",\"authors\":\"José G. Jiménez-Montero, G. Haft\",\"doi\":\"10.2147/RRED.S50952\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Research and Reports in Endocrine Disorders 2015:5 1–13 Research and Reports in Endocrine Disorders Dovepress\",\"PeriodicalId\":90317,\"journal\":{\"name\":\"Research and reports in endocrine disorders\",\"volume\":\"5 1\",\"pages\":\"1-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/RRED.S50952\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research and reports in endocrine disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/RRED.S50952\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and reports in endocrine disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRED.S50952","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence
(unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Research and Reports in Endocrine Disorders 2015:5 1–13 Research and Reports in Endocrine Disorders Dovepress
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
